Funding, M&A and exec moves matched to your market — guaranteed to pay for itself in a year, or we refund it. See terms for full details.See plans →

Curavit acquires Lindus Health CRO assets

PRIVATEAug 18, 2026•about 5 hours ago

Acquiring Company

Curavit Clinical Research

Acquired Company

Lindus Health

Scarsdale

New YorkBiotechnologyHealthcareHealth CareTherapeuticsSoftwareHealth Care

Description

Curavit Clinical Research has acquired the CRO assets of Lindus Health, expanding its capabilities in clinical research. This acquisition allows Curavit to offer unified clinical trial solutions across North America and Europe. The transaction facilitates faster recruitment and streamlined operations for life science sponsors. This strategic move addresses the growing demands of life science companies for efficient trial execution.

Company Information

Company

Curavit Clinical Research

Location

18 LARCH LANE

Scarsdale, New York, United States

About

Curavit, the “First All-Virtual CRO", designs and executes decentralized - or “virtual” - clinical trials. Curavit leverages emerging technologies in digital health, cloud computing, and data science to recruit, engage, and monitor diverse patient populations from wherever they live, work, or study; eliminating the need for physical infrastructure and travel, while increasing data quality. Curavit brings together the world’s leading researchers, enrolls previously untapped and underserved patient populations, applies machine learning algorithms to health and social engagement information to recruit participants, and leverages leading telehealth, patient data, and medical device technologies. Curavit’s central virtual site supports remote monitoring and is always audit ready.

Don't miss Curavit Clinical Research's next move

Get an email the moment Curavit Clinical Research makes an acquisition, hires an exec, or expands — usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Choose your plan to reveal verified contacts

Predictive Intelligence

Strategic

ML-powered predictions for Curavit Clinical Research's next move

Learn about Strategic plan

M&A Insights

Based on deal data

Integration timeline

70% of M&A integrations take 12-24 months to complete

Tech stack consolidation

83% of merged companies consolidate technology vendors within first year

Post-acquisition investment

Companies increase IT spending by 23% on average after acquisitions

Success factor

M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired Lindus Health?

Lindus Health was acquired by Curavit Clinical Research, based in Scarsdale. The deal was reported on August 18, 2026. Curavit, the “First All-Virtual CRO", designs and executes decentralized - or “virtual” - clinical trials. Curavit Clinical Research is privately held and operates in Biotechnology.

When did Curavit Clinical Research acquire Lindus Health?

Curavit Clinical Research's acquisition of Lindus Health was reported on August 18, 2026. Curavit Clinical Research has acquired the CRO assets of Lindus Health, expanding its capabilities in clinical research. This acquisition allows Curavit to offer unified clinical trial solutions across North America and Europe. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Lindus Health do?

Lindus Health’s mission is to fix this problem, to enable the next generation of healthcare. Lindus Health is focused on working with start-ups and growth companies to deliver trials better, faster, and cheaper. It is privately held, operating in Software, and is based in New York.